These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 1650149)

  • 1. The role of tumor necrosis factor-alpha in bone resorption of cholesteatoma.
    Yan SD; Huang CC
    Am J Otolaryngol; 1991; 12(2):83-9. PubMed ID: 1650149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Third place--Resident Basic Science Award 1990. Interleukin 1 causing bone destruction in middle ear cholesteatoma.
    Ahn JM; Huang CC; Abramson M
    Otolaryngol Head Neck Surg; 1990 Oct; 103(4):527-36. PubMed ID: 2174138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autocrine regulation of osteoclast formation and bone resorption by IL-1 alpha and TNF alpha.
    Tani-Ishii N; Tsunoda A; Teranaka T; Umemoto T
    J Dent Res; 1999 Oct; 78(10):1617-23. PubMed ID: 10520966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible role for nitric oxide in osteoclastogenesis associated with cholesteatoma.
    Jung JY; Pashia ME; Nishimoto SY; Faddis BT; Chole RA
    Otol Neurotol; 2004 Sep; 25(5):661-8. PubMed ID: 15353992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet-derived growth factor in middle ear cholesteatoma.
    Fujioka O; Huang CC
    Eur Arch Otorhinolaryngol; 1994; 251(4):199-204. PubMed ID: 7917251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-4 directly inhibits tumor necrosis factor-alpha-mediated osteoclast formation in mouse bone marrow macrophages.
    Kitaura H; Nagata N; Fujimura Y; Hotokezaka H; Tatamiya M; Nakao N; Yoshida N; Nakayama K
    Immunol Lett; 2003 Sep; 88(3):193-8. PubMed ID: 12941478
    [TBL] [Abstract][Full Text] [Related]  

  • 8. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
    Perez-Amodio S; Beertsen W; Everts V
    J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipopolysaccharide of Aggregatibacter actinomycetemcomitans up-regulates inflammatory cytokines, prostaglandin E2 synthesis and osteoclast formation in interleukin-1 receptor antagonist-deficient mice.
    Mizutani H; Ishihara Y; Izawa A; Fujihara Y; Kobayashi S; Gotou H; Okabe E; Takeda H; Ozawa Y; Kamiya Y; Kamei H; Kikuchi T; Yamamoto G; Mitani A; Nishihara T; Noguchi T
    J Periodontal Res; 2013 Dec; 48(6):748-56. PubMed ID: 23586622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tumor necrosis factor alpha in particulate-induced bone resorption.
    Algan SM; Purdon M; Horowitz SM
    J Orthop Res; 1996 Jan; 14(1):30-5. PubMed ID: 8618163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis.
    Sabokbar A; Kudo O; Athanasou NA
    J Orthop Res; 2003 Jan; 21(1):73-80. PubMed ID: 12507582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of collagenase in human middle ear cholesteatoma.
    Abramson M; Huang CC
    Laryngoscope; 1977 May; 87(5 Pt 1):771-91. PubMed ID: 191705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of interleukin 6 in epithelial hyperproliferation and bone resorption in middle ear cholesteatomas.
    Bujía J; Kim C; Ostos P; Kastenbauer E; Hültner L
    Eur Arch Otorhinolaryngol; 1996; 253(3):152-7. PubMed ID: 8652157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pressures exerted by experimental cholesteatomas.
    Orisek BS; Chole RA
    Arch Otolaryngol Head Neck Surg; 1987 Apr; 113(4):386-91. PubMed ID: 3814388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of tumor necrosis factor-alpha (TNF-alpha) in bone resorption present in middle ear cholesteatoma.
    Vitale RF; Ribeiro Fde A
    Braz J Otorhinolaryngol; 2007; 73(1):117-21. PubMed ID: 17505610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
    Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
    Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2, interleukin 1alpha, and tumor necrosis factor-alpha increase human osteoclast formation and bone resorption in vitro.
    Lader CS; Flanagan AM
    Endocrinology; 1998 Jul; 139(7):3157-64. PubMed ID: 9645689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha in middle ear cholesteatoma and its effect on keratinocytes in vitro.
    Yan SD; Huang CC
    Ann Otol Rhinol Laryngol; 1991 Feb; 100(2):157-61. PubMed ID: 1671546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aural cholesteatoma: role of tumor necrosis factor-alpha in bone destruction.
    Sastry KV; Sharma SC; Mann SB; Ganguly NK; Panda NK
    Am J Otol; 1999 Mar; 20(2):158-61. PubMed ID: 10100515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement by conditioned medium of stretched calvarial bone cells of the osteoclast-like cell formation induced by parathyroid hormone in mouse bone marrow cultures.
    Soma S; Matsumoto S; Takano-Yamamoto T
    Arch Oral Biol; 1997 Mar; 42(3):205-11. PubMed ID: 9188990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.